Moderna cancer vaccine succeeds in Phase 3, but "AI cured cancer" claims debunked

Merck and Moderna announced that their personalized mRNA cancer therapy mRNA-4157 (Intismeran), combined with Keytruda, met its primary endpoint in a Phase 3 trial of 1,137 post-surgery high-risk melanoma patients, significantly extending recurrence-free survival and distant metastasis-free survival. After the news broke, claims like "AI invented a cancer vaccine overnight" and "the first AI-assisted cure for cancer" went viral on social media, only to be debunked by multiple scholars. The current consensus: the scientific progress is real and significant, but the AI narrative was heavily exaggerated.

Confirmed

Why it matters

2026-08-20 ~ 2026-08-20 · 5 related posts

Full story(2 episodes)→

Primary sources